Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostatin with Chemoradiotherapy in Esophageal Cancer
NCT02745561Phase 2Unknown
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in esophageal cancer. Status: unknown.
02
Drugs
endostar
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT02745561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02745561.